Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

30 results about "Isopropylmalic acid" patented technology

Isopropylmalic acid (isopropylmalate) is an intermediate in the biosynthesis of leucine, synthesized from oxoisovalerate by 2-isopropylmalate synthase and converted into isopropyl-3-oxosuccinate by 3-isopropylmalate dehydrogenase. Two isomers are important, the 2- and 3-isopropyl derivatives, and these are interconverted by isopropylmalate dehydratase.

DNA sequence, recombinant vector, single and double auxotrophic Hansenula polymorpha, and preparation method thereof

The invention relates to a double auxotrophic yeast, wherein the yeast is Hansenula polymorpha, and the orotic glycoside-5-phosphate decarboxylase gene and the beta-isopropyl malate dehydrogenase gene of the Hansenula polymorpha are blocked. The invention also relates to a preparation method of the double auxotrophic yeast. In addition, the invention also provides a DNA sequence and a recombinant vector used to prepared the double auxotrophic yeast. The double auxotrophic yeast of the invention has the advantages of low reverse mutation, high genetic stability, high biomass, and the like, and plays an important role in genetic engineering vaccine production; for example, HPV16-type L1 and 58L2 protein have double expression with high efficiency in the yeast.
Owner:BEIJING INST OF BIOLOGICAL PROD

Processes to prepare elongated 2-ketoacids and c6-c10 compounds therefrom via genetic modifications to microbial metabolic pathways

Modification of metabolic pathways includes genetically engineering at least one enzyme involved in elongating 2-ketoacids during leucine biosynthesis, and preferably at least isopropylmalate dehydrogenase or synthase (LeuB or LeuA in E. coli), to include at least such non- native enzyme, enzyme complex, or combination thereof to convert 2-ketobutyrate or 2-ketoisovalerate to a C7-C11 2-ketoacid, wherein the production of such is at a higher efficiency than if a purely native pathway is followed. The C7-C11 2-ketoacid may then be converted, via a native or genetically engineered thiamin dependent decarboxylase, to form a C6-C10 aldehyde having one less carbon than the C7-C11 2-ketoacid being converted. In some embodiments the C6-C10 aldehyde may then be converted via additional native or genetically engineered enzymes to form other C6-C10 products, including alcohols, carboxylic acids, and alkanes. This genetic engineering offers the opportunity for commercial scale of in vivo biosynthetic processes that may be more cost-efficient than non- biobased approaches to produce the same products.
Owner:DOW GLOBAL TECH LLC

Beta-isopropylmalate dehydrogenase and application of beta-isopropylmalate dehydrogenase in lipid synthesis

ActiveCN110499300AImprove biosynthetic abilityOxidoreductasesFermentationFatty acid biosynthesisMicroorganism
The invention discloses beta-isopropylmalate dehydrogenase and application of the beta-isopropylmalate dehydrogenase in lipid synthesis, and belongs to the technical fields of gene engineering and microbial engineering. An amino acid sequence of the beta-isopropylmalate dehydrogenase is shown in SEQ ID No. 1, and the beta-isopropylmalate dehydrogenase has a function of promoting microorganism to produce fatty acids. Recombinant mortierella alpina containing the beta-isopropylmalate dehydrogenase is subjected to shake cultivation for 7 d, so that the fatty acid content in the mortierella alpinacontaining the beta-isopropylmalate dehydrogenase can reach 46.4% of dry cell weight, and is 20.2% higher than that of mortierella alpina without the beta-isopropylmalate dehydrogenase. According tothe beta-isopropylmalate dehydrogenase, through gene engineering, the fatty acid production ability of the mortierella alpine and other oil producing microorganisms is further improved, and solid theoretical support for improving the fatty acid biosynthesis ability is provided.
Owner:JIANGNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products